KRAS mutations in patients with colorectal cancer in Libya

Large prospective clinical trials have demonstrated that colorectal cancers (CRCs) with wild-type KRAS respond favorably to anti-epidermal growth factor receptor treatment, thus making mutational analysis obligatory prior to treatment. In our study, frozen CRC tissues from Libyan patients were analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Abudabous, Asma, Drah, Mustafa, Aldehmani, Mamdouh, Parker, Iqbal, Alqawi, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375022/
https://www.ncbi.nlm.nih.gov/pubmed/34462653
http://dx.doi.org/10.3892/mco.2021.2359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375022/
https://www.ncbi.nlm.nih.gov/pubmed/34462653
http://dx.doi.org/10.3892/mco.2021.2359

Ejemplares similares